Your session is about to expire
← Back to Search
Behavioural Intervention
Financial Incentives for Smoking Cessation
N/A
Recruiting
Led By Michelle R vanDellen, PhD
Research Sponsored by University of Georgia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to study the effectiveness of financial incentives for smoking cessation in dual-smoker couples (DSCs). DSCs are less likely to try to quit smoking and more likely to relapse
Who is the study for?
This trial is for couples where both partners smoke cigarettes. They must be willing to try quitting together and participate in a study that involves financial incentives as motivation. Specific eligibility details are not provided, but typically participants would need to meet certain health criteria and commit to the study's schedule.
What is being tested?
The trial tests two versions of Financial Incentive Treatments (FITs) designed to help dual-smoker couples quit smoking. Participants will receive usual care plus potential cash rewards for abstaining from smoking at set intervals. One group gets incentives just for one partner, while the other group has both partners receiving incentives.
What are the potential side effects?
Since this trial involves financial incentives rather than medical treatments or drugs, there aren't traditional side effects like you'd expect with medication. However, stress or tension could arise from trying to quit smoking, especially under a structured program.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Point-Prevalence Abstinence at End of Treatment
Secondary study objectives
Partner Point-Prevalence Abstinence
Point-Prevalence Abstinence After Treatment
Point-Prevalence Abstinence at First Follow-up
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Single-Target FIT (SFIT)Experimental Treatment1 Intervention
One couple member offered incentives. Targets in the SFIT condition will be offered financial incentives for biochemically verified abstinence ($200 at each of three follow-ups \[1, 3, and 6 Month\]).
Group II: Dyadic-FIT condition (DFIT)Experimental Treatment1 Intervention
Both couple members offered incentives and tracked across 12 months. Both targets and partners will be offered financial incentives for abstinence. Thus, in this condition, the total financial incentives offered to the dyad are twice the amount as offered to participants in the SFIT condition.
Group III: No-FIT Treatment-as-Usual (TAU) ConditionActive Control1 Intervention
Participants in the no-FIT control condition will not receive incentives.
Find a Location
Who is running the clinical trial?
University of GeorgiaLead Sponsor
104 Previous Clinical Trials
44,218 Total Patients Enrolled
McMaster UniversityOTHER
918 Previous Clinical Trials
2,615,393 Total Patients Enrolled
University of KentuckyOTHER
194 Previous Clinical Trials
222,825 Total Patients Enrolled
Michelle R vanDellen, PhDPrincipal InvestigatorUniversity of Georgia
1 Previous Clinical Trials
190 Total Patients Enrolled